Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thyroid Nodule 1Prostatic Neoplasms 1Primary Peritoneal Neoplasm 1Ischemia 1Hemorrhage 1Cholecystolithiasis 1Blood Loss, Surgical 1

Interventions

Misoprostol 3Tranexamic Acid 2Saline Solution 2Aprotinin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1carbetocin 1Vasopressins 1Uterine Myomectomy 1Tourniquets 1Tidal Volume 1Terlipressin 1Sodium Chloride 1Ringer's Solution 1Ringer's Lactate 1Population Groups 1Oxytocin 1Neuromuscular Blockade 1Ethamsylate 1Embolization, Therapeutic 1Cerebral Angiography 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Blood Loss, Surgical × Ringer's Solution × Clear all
NCT00425334 2013-08-19

Safety Study of HemospanĀ® in Prostatectomy Patients

Sangart

Phase 2 Completed
20 enrolled
Genitourinary

Hemorrhage, Ischemia, Prostatic Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon ⚔